Core Insights - Rollins, Inc. (ROL) is scheduled to report its fourth-quarter 2025 results on February 11, with a strong earnings surprise history, surpassing the Zacks Consensus Estimate in two of the last four quarters and matching twice, averaging a 3.2% earnings surprise [1] Revenue Expectations - The Zacks Consensus Estimate for revenues in the upcoming quarter is $922.1 million, reflecting a year-over-year increase of 10.8% [2] - Residential revenues are estimated at $407 million, indicating a 10.3% increase from the previous year, while commercial revenues are expected to rise 11.4% year over year to $312.4 million [3] - Termite and ancillary revenues are projected at $195.5 million, suggesting a 13.4% growth year over year, with franchise revenues estimated at $4.3 million, showing a marginal rise [3] - U.S. revenues are pegged at $858.3 million, indicating an 11.3% increase from the year-ago quarter, while revenues from other countries are anticipated to grow 9.6% year over year to $66.9 million [5] Growth Drivers - The anticipated revenue growth is attributed to Orkin's expansion, which has the highest customer retention rate among the company's service lines, and the utilization of advanced digital tools such as BOSS, VRM, Orkin 2.0, BizSuite, and InSite [4] - Recent acquisitions of Saela Holdings and FPC Holdings are expected to enhance geographical exposure to favorable regions, while increased media engagement through social media platforms like TikTok and Facebook is likely to boost brand popularity [6] Earnings Outlook - The consensus estimate for earnings is set at 27 cents per share, indicating a year-over-year growth of 17.4% [6] - The bottom line is expected to benefit from the company's CPI-plus focused pricing strategies, which aim to keep prices above the general Consumer Price Index (CPI) rate to mitigate inflation effects [7] Earnings Prediction Model - The current model does not predict a definitive earnings beat for ROL, as it has an Earnings ESP of 0.00% and a Zacks Rank of 3 (Hold) [8]

Core Insights - DraftKings Inc. (DKNG) is set to report its fourth-quarter 2025 results on February 12, with an earnings miss of 8.3% in the last quarter [2] Financial Estimates - The Zacks Consensus Estimate for fourth-quarter adjusted earnings per share has risen to 50 cents from 45 cents over the past 30 days, compared to an adjusted loss per share of 28 cents in the same quarter last year [3] - Revenue consensus is projected at $1.99 billion, reflecting a 42.9% year-over-year increase [3] Revenue Drivers - Strong sportsbook engagement, particularly around the NFL and early NBA seasons, is expected to have significantly contributed to fourth-quarter revenues, with increased customer activity and improved retention [4] - Continued acceleration in iGaming growth, driven by more active users and higher spending per customer, is likely to have provided a more stable revenue stream [5] - Marketing leverage and brand partnerships, especially with ESPN and NBCUniversal, have enhanced customer engagement and brand reach without substantial additional spending [6] Earnings Performance - Structural margin improvements, driven by a richer bet mix and disciplined promotional spending, are anticipated to have positively impacted earnings [7] - Operating leverage from previous investments in technology and customer management is expected to have limited cost growth despite increased volumes [7] Earnings Prediction Model - The current model does not predict an earnings beat for DraftKings, as it lacks a positive Earnings ESP and holds a Zacks Rank of 4 (Sell) [8][10]

Core Viewpoint - Smurfit Westrock PLC (SW) is expected to report fourth-quarter 2025 results on February 11, with revenues projected at $7.67 billion, reflecting a 1.7% year-over-year growth, and earnings per share (EPS) estimated at 46 cents, up from 34 cents in the previous year [1][5]. Financial Estimates - The Zacks Consensus Estimate for revenues is $7.67 billion, indicating a 1.7% increase from the same quarter last year [1][5]. - The EPS consensus is set at 46 cents, showing a rise from 34 cents year-over-year [1][5]. - The earnings surprise history shows that the company has beaten the Zacks Consensus Estimate once in the last four quarters, with an average negative surprise of 18.4% [2]. Segment Performance - The Europe, MEA, and APAC segment is projected to generate revenues of $2.74 billion, up from $2.51 billion in the fourth quarter of 2024, with adjusted EBITDA estimated at $426 million, an increase from $371 million [7]. - North America's revenue estimate for Q4 2025 is $4.49 billion, slightly down from $4.52 billion reported in the previous year, with adjusted EBITDA expected to be $716 million, indicating a 0.8% year-over-year growth [8]. - The LATAM segment's revenue is estimated at $533 million, up from $505 million, but adjusted EBITDA is projected to decline to $116 million from $121 million in the prior-year quarter [9]. Market Trends and Challenges - Demand for corrugated packaging and containerboard remains stable, driven by e-commerce growth and the need for sustainable packaging solutions [3]. - However, weak volumes in Europe and lower box demand are anticipated to negatively impact quarterly results [4][5]. - Merger-related costs are expected to affect performance and free cash flow margin, although pricing actions and cost-saving initiatives may mitigate some of these challenges [6]. Stock Performance - Smurfit Westrock's stock has declined by 14.2% over the past year, compared to a 6.1% decline in the industry [11].

Core Viewpoint - West Pharmaceutical Services (WST) is expected to report fourth-quarter 2025 results on February 12, with a history of earnings surprises, averaging 15.52% over the last four quarters [2][3]. Q4 Estimates - The company anticipates fourth-quarter revenues between $790 million and $800 million, indicating organic sales growth of 1% to 2.3%. Adjusted diluted earnings per share (EPS) are projected to be between $1.81 and $1.86 [3][10]. - The Zacks Consensus Estimate for revenues stands at $794.3 million, reflecting a year-over-year growth of 6.1%, while the consensus for earnings is $1.83 per share, showing a 0.6% improvement [3]. Revenue Breakdown - Total revenues are estimated at $792.7 million, suggesting a 2.5% organic improvement year over year. The Proprietary Products segment is expected to generate $645.3 million (1.9% organic growth), while Contract-Manufactured Products are projected at $147.4 million [4]. - Operating profit for the Proprietary Products segment is likely to increase by 2.2%, whereas the Contract-Manufactured Products segment is expected to decline by 13.9% [4]. Factors Influencing Sales - Sales growth in Q4 is anticipated to be driven by strong demand for West Pharmaceutical's high-value product (HVP) portfolio, which has a higher margin that may positively impact gross margin [5]. - The company raised its growth estimate for the HVP portfolio by 50 basis points, indicating ongoing strength despite a projected unfavorable tariff impact of $15 million to $20 million for the full year [5]. Segment Performance - The Proprietary Products segment includes HVP Components, HVP Delivery Devices, and Standard Products, serving various medical companies [6]. - The HVP Components business accounted for 48% of total sales in Q3 2025, with organic growth of 13.3% year over year, driven by demand for GLP-1s and biologics [7]. - Despite manufacturing constraints in Germany, similar growth trends are expected to continue in Q4, although a $25 million incentive from the previous quarter may not recur, potentially affecting sales [8]. Cost Management and Product Transition - Growth in laminated technology products and strong performance in Westar and Envision are expected to partially offset the absence of the prior incentive [9]. - The Standard Products business is likely to maintain moderate growth, aided by HVP upgrades due to new regulations in Europe [9][11]. Contract Manufacturing Segment - The Contract Manufacturing segment is expected to benefit from ongoing demand for self-injected devices for obesity and diabetes, with potential pricing improvements [12]. However, lower demand for healthcare diagnostic devices may partially counterbalance these gains [12].

Core Insights - International Flavors & Fragrances Inc. (IFF) is set to report its fourth-quarter 2025 results on February 11, with sales expected to be $2.51 billion, reflecting a 9.7% decline year-over-year [1][6] - The earnings estimate is pegged at 85 cents per share, indicating a year-over-year decrease of 12.4% [1][6] - IFF has a history of beating earnings estimates, achieving an average surprise of 9.5% over the past four quarters [3][6] Sales and Earnings Estimates - The Zacks Consensus Estimate for IFF's sales is $2.51 billion, down 9.7% from the previous year [1][6] - Earnings per share (EPS) is estimated at 85 cents, unchanged over the past 60 days [1] - The company has an Earnings ESP of +3.50%, suggesting a potential earnings beat [4] Segment Performance Projections - The Taste segment's sales are projected to decline by 0.8% year-over-year to $572 million, with adjusted operating EBITDA expected to grow by 29.3% to $113 million [10] - The Food Ingredients segment is anticipated to see a 2.7% decrease in sales to $797 million, with adjusted operating EBITDA declining by 2.7% to $98 million [10] - The Scent segment's sales are expected to decrease by 2% to $567 million, with operating EBITDA projected to rise by 1% to $107 million [11] - The Health & Biosciences segment is projected to have sales of $542 million, reflecting a 1.5% decrease, and operating EBITDA is expected to decline by 4% to $131 million [12] Cost and Margin Considerations - IFF has experienced volume growth and productivity gains, but high raw material costs and additional expenses related to labor, shipping, and cleaning are likely to have pressured margins [6][8] - Despite pricing actions and cost-reduction efforts, these factors are expected to negatively impact margins in the upcoming quarter [8] Stock Performance - Over the past year, IFF shares have decreased by 9.1%, contrasting with the industry's growth of 1.7% [13]

Core Insights - CBRE Group, Inc. is set to announce its fourth-quarter 2025 earnings on February 12, showcasing its leadership in real estate services with a comprehensive suite of offerings [2] - The company reported a 9.52% earnings surprise in the last quarter, with a year-over-year revenue growth of 14%, although the Real Estate Investments segment did not perform as well [3][4] Financial Performance - Over the past four quarters, CBRE has consistently surpassed the Zacks Consensus Estimate, with an average earnings beat of 8.5% [4] - The Zacks Consensus Estimate for quarterly revenues is projected at $11.51 billion, indicating a 10.65% year-over-year increase [8] - Advisory Services revenue is expected to reach $2.77 billion, up from nearly $2.2 billion in the prior quarter, while revenues from Building Operations & Experience are estimated at $6.32 billion, an increase from $5.79 billion [8] Market Trends and Opportunities - The company is likely to benefit from a balanced operating model with a focus on contractual revenues and increasing demand for outsourcing services [5][10] - CBRE's enterprise businesses may see support from new client acquisitions and expansions in technology, life sciences, and healthcare sectors [6] Challenges and Outlook - Despite positive trends, ongoing macroeconomic uncertainty and a competitive landscape may impact commercial real estate transaction activity [7] - Analysts have shown some pessimism regarding the company's earnings prospects, with the consensus estimate for earnings per share (EPS) decreasing by 3 cents to $2.66, although this still represents a 14.7% year-over-year increase [9]

Core Viewpoint - Ford is expected to report its fourth-quarter 2025 results, with an EPS estimate of 17 cents and automotive revenues of $41.2 billion, reflecting a year-over-year decline in both metrics [1][2]. Earnings Estimates - The EPS estimate for the upcoming quarter has increased by 10 cents over the past month, but it still represents a 56% decline year-over-year. Revenue estimates indicate an 8% decrease compared to the same quarter last year [2]. - For the full year 2025, automotive revenues are projected at $173 billion, showing a modest 1% increase year-over-year, while the EPS consensus indicates a 39% contraction. However, the EPS for 2026 is expected to grow by 35.2% from 2025 levels [3]. Performance Indicators - Ford has consistently surpassed earnings estimates in the past four quarters, and current indicators suggest a strong likelihood of an earnings beat this time, supported by an Earnings ESP of +16.06% and a Zacks Rank of 1 [4]. - The most accurate EPS estimate for the current quarter is 19 cents, while the Zacks Consensus Estimate is 17 cents [5]. Sales and Market Dynamics - Ford's overall sales rose by 2.7% in Q4 2025, totaling over 545,200 vehicles, with hybrid sales increasing by 17.6% year-over-year [8]. - The company faces challenges in its EV segment, with a significant drop in EV sales exceeding 50% due to the withdrawal of the federal EV tax credit, particularly affecting F-150 Lightning volumes [6][7]. Strategic Initiatives - Ford anticipates $19.5 billion in special charges related to restructuring its U.S. EV strategy, with $5.5 billion impacting cash flows through 2026 and 2027 [7]. - The Ford Pro unit is expected to contribute positively, with projected revenues of approximately $15 billion and EBIT of $1.4 billion, driven by rising paid software subscriptions [9]. Market Position and Valuation - Over the past six months, Ford's shares have increased by 24%, outperforming the industry and Tesla, while underperforming General Motors [10]. - The company is currently trading at a forward sales multiple of 0.32, indicating it may be undervalued compared to the industry [13]. Future Growth Prospects - Ford is shifting its focus towards hybrids and gas-powered vehicles in response to slowing EV adoption, which is expected to help maintain margins and volume [15]. - The company is also exploring future growth avenues, including a battery energy storage systems business and advancements in autonomous driving technology [18].

Core Insights - Antero Midstream Corporation (AM) is scheduled to report its fourth-quarter 2025 results on February 11, after market close [1] - In the last reported quarter, AM's adjusted earnings of 24 cents per share fell short of the Zacks Consensus Estimate of 25 cents due to increased operating expenses, although higher gathering and compression volumes helped mitigate the impact [1] Earnings Performance - AM has beaten earnings estimates in two of the last four quarters, missed in one, and reported breakeven in another, resulting in an average earnings surprise of 3.26% [2] - The Zacks Consensus Estimate for fourth-quarter earnings per share remains at 24 cents, reflecting no revisions in the past week, which indicates a 4.4% improvement from the same quarter last year [3] Revenue Expectations - The Zacks Consensus Estimate for revenues in the fourth quarter is projected at $293.9 million, representing a 2.2% increase from the year-ago figure [3][8] - AM is expected to generate revenue from stable, fee-based contracts primarily with Antero Resources Corporation for the transportation and processing of natural gas and liquefied petroleum gas [4] Earnings Prediction - The earnings model suggests a potential earnings beat for AM, supported by a positive Earnings ESP of +0.84% and a Zacks Rank of 3 (Hold) [5] - The company is anticipated to report revenues from its pipeline, gathering, compression, processing, and water services assets [8]

Core Insights - Crocs, Inc. (CROX) is expected to report fourth-quarter 2025 results on February 12, with revenue estimates at $916.6 million, reflecting a 7.4% decline year-over-year. Earnings per share are estimated at $1.91, indicating a 24.2% decrease from the previous year [1][3]. Financial Performance - The company has a trailing four-quarter earnings surprise average of 14.3%, with the last quarter's earnings exceeding estimates by 22.2% [2]. - Management projected a revenue decline of approximately 8% year-over-year, with Crocs brand revenues expected to drop around 3% and HEYDUDE brand revenues anticipated to fall mid-20% [5]. Operational Challenges - Crocs is facing a challenging operating environment, with margins pressured by increased expenses, tariffs, and higher selling, general and administrative (SG&A) costs [3][9]. - The HEYDUDE brand has been experiencing weak trends, with revenue estimates for the quarter at $175 million, down about 23% year-over-year due to cautious consumer behavior and wholesale channel pressures [4][9]. Brand Performance - Despite challenges, Crocs has seen strength in its core products, including clogs, sandals, and personalization offerings, which may help cushion overall performance [6][9]. - The Jibbitz business has also shown encouraging results, contributing positively to the company's performance [6]. Valuation - Crocs is currently trading at a forward 12-month price-to-earnings ratio of 6.83x, significantly below its five-year high of 25.08x and the industry average of 16.16x, indicating an attractive investment opportunity [10]. - The company's shares have increased by 12.1% over the past six months, contrasting with a 2.7% decline in the industry [10].

Core Viewpoint - Martin Marietta Materials, Inc. is expected to report its fourth-quarter 2025 results on February 11, with earnings and revenues anticipated to decline year-over-year due to various market pressures [1][3][4]. Financial Performance - In the last quarter, Martin Marietta's earnings from continuing operations and revenues missed the Zacks Consensus Estimate by 10.2% and 9.9%, respectively, but showed year-over-year growth of 23% and 12% [1]. - The Zacks Consensus Estimate for fourth-quarter earnings per share has decreased from $4.83 to $4.68, indicating a 2.3% decline from the previous year's figure of $4.79 [3]. - The estimated revenue for the fourth quarter is projected at $1.56 billion, reflecting a 4.7% decrease from the prior year's $1.63 billion [3]. Market Conditions - The company's revenue performance is expected to be impacted by a slowdown in private construction activities and seasonal factors, with affordability concerns due to high mortgage rates affecting the single-family housing market [4][11]. - The revenue from the Building Materials business is estimated at $1.44 billion, down 7.3% year-over-year [5]. Strategic Factors - Despite the challenges, Martin Marietta benefits from resilient public infrastructure spending, a disciplined pricing strategy, and ongoing portfolio transformation under its SOAR 2025 plan [6][11]. - The aggregates business is supported by sustained public investment in infrastructure projects such as highways, bridges, and tunnels [6]. Earnings Outlook - The bottom line for the upcoming quarter is expected to decline year-over-year due to reduced top-line leverage, increased costs, and ongoing macroeconomic uncertainties [7][11]. - The company's Earnings ESP is -1.31%, indicating that an earnings beat is not anticipated this time [8].